Clinical trial
Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
NCT04594746 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
- Lead sponsor
- University of Calgary
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 3, 2022
- Completion date
- January 20, 2026
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.